Lymphocyte-Rich Hepatocellular Carcinoma with Multiple Lymphadenopathy and Positive Epstein–Barr Virus Encoding Region

Lymphocyte-rich hepatocellular carcinoma (HCC) represents the rarest subtype among the various subgroups of HCC, and limited clinical data are available for this particular subtype. It is commonly observed as a solitary lesion and tends to present at an early stage. Histopathological examination typically reveals tumor cells infiltrated by a lymphocyte-rich background, leading to its designation as lymphoepithelioma-like HCC. Unlike other lymphoepithelioma-like tumors associated with the Epstein–Barr virus (EBV), lymphocyte-rich HCC is predominantly negative for EBV. This subtype is characterized by more favorable clinical outcomes and prognosis compared to conventional HCC. Here, we present a case of lymphocyte-rich hepatocellular carcinoma (HCC) characterized by the presence of bilateral hepatic tumors and concurrent multiple lymphadenopathy. Interestingly, contrary to previous literature, the examination for the Epstein–Barr virus (EBV) revealed a positive result in this particular case.

[1]  Dekang Lin,et al.  Plasma Epstein-Barr virus DNA and risk of nasopharyngeal carcinoma in a prospective seropositive population , 2021, BMC cancer.

[2]  S. Raman,et al.  Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. , 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

[3]  Y. N. Park,et al.  Histopathological Variants of Hepatocellular Carcinomas: an Update According to the 5th Edition of the WHO Classification of Digestive System Tumors , 2020, Journal of liver cancer.

[4]  R. Lo.  An update on the histological subtypes of hepatocellular carcinoma , 2019 .

[5]  N. Wong,et al.  Genomic landscape of lymphoepithelioma‐like hepatocellular carcinoma , 2019, The Journal of pathology.

[6]  Deokhoon Kim,et al.  Immunogenomic landscape of hepatocellular carcinoma with immune cell stroma and EBV-positive tumor-infiltrating lymphocytes. , 2019, Journal of hepatology.

[7]  P. Schirmacher,et al.  Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  P. Schirmacher,et al.  Correction to: "Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up". , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  A. Stueck,et al.  Lymphoepithelioma-Like Carcinoma in Liver. , 2017, The American journal of pathology.

[10]  M. Torbenson.  Morphologic Subtypes of Hepatocellular Carcinoma. , 2017, Gastroenterology clinics of North America.

[11]  A. Luciani,et al.  Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features , 2016, Hepatology.

[12]  J. W. Lam,et al.  Clinical utility of circulating Epstein-Barr virus DNA analysis for the management of nasopharyngeal carcinoma. , 2016, Chinese clinical oncology.

[13]  V. Wong,et al.  Lymphoepithelioma-like Hepatocellular Carcinoma: An Uncommon Variant of Hepatocellular Carcinoma With Favorable Outcome , 2015, The American journal of surgical pathology.

[14]  P. Lai,et al.  Epstein–Barr virus‐associated lymphoepithelioma‐like cholangiocarcinoma: a rare variant of intrahepatic cholangiocarcinoma with favourable outcome , 2014, Histopathology.

[15]  W. Lau,et al.  Positive Lymph Node Metastasis Has a Marked Impact on the Long-Term Survival of Patients with Hepatocellular Carcinoma with Extrahepatic Metastasis , 2014, PloS one.

[16]  T. Rong,et al.  Primary pulmonary lymphoepithelioma‐like carcinoma , 2012, Cancer.

[17]  K. To,et al.  Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches. , 2012, Seminars in cancer biology.

[18]  C. Park,et al.  Host inflammatory response predicts survival of patients with Epstein-Barr virus-associated gastric carcinoma. , 2010, Gastroenterology.

[19]  G. Sotiropoulos,et al.  Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.